PMID: 2495076Feb 25, 1989Paper

Effects of social class, sex, and region of residence on age at death from cystic fibrosis

BMJ : British Medical Journal
J R Britton

Abstract

To determine the time trend in age at death from cystic fibrosis and the independent effects of social class, sex, and region of residence mortality data for England and Wales from 1959 to 1986 were analysed. Median age at death increased from 6 months in 1959 to 17 years in 1986 and was higher in most years from 1970 in male patients (by one to six years) and in social classes with non-manual occupations (by one to 12 years). Independent odds ratios for death above the median age for the year of death (calculated for years from 1974, when regions of residence were coded by regional health authority area) were 1.47 (95% confidence interval 1.16 to 1.87) in male compared with female patients and 2.75 (2.16 to 3.52) in non-manual compared with manual social classes. The independent odds of death at above the median age also varied significantly among regions of residence by a ratio of up to 2.67. Social class, sex, and region of residence are all potential determinants of survival of patients with cystic fibrosis. Social class is particularly likely to confound the effect of management in specialist centres on survival.

References

Apr 7, 1979·The Medical Journal of Australia·P D PhelanG L Barnes
May 1, 1978·Pediatric Research·J D KnokeL W Matthews
Sep 1, 1976·The Journal of Pediatrics·R C SternL W Matthews
Dec 1, 1975·Journal of Chronic Diseases·W J WarwickC J Nesbitt
Jul 1, 1987·Thorax·A R PenkethJ C Batten
Jul 1, 1985·American Journal of Diseases of Children·R W WilmottD J Matthew
Apr 1, 1972·Archives of Disease in Childhood·J F McPartlinV A Swain
Oct 1, 1970·American Journal of Diseases of Children·N N HuangA Sproul
Apr 1, 1971·Archives of Disease in Childhood·L George, A P Norman
Oct 1, 1983·Archives of Disease in Childhood·R W WilmottD J Matthew
Jan 1, 1984·Archives of Disease in Childhood·P Phelan, E Hey
Dec 1, 1980·Australian Paediatric Journal·J L AllanD M Danks
Oct 1, 1956·A.M.A. Journal of Diseases of Children·R R DOOLEYC WEIL
Jan 1, 1958·Journal of Chronic Diseases·D H ANDERSEN
Jul 1, 1965·British Journal of Diseases of the Chest·E G ANDERSONH M BROWN
Sep 3, 1960·Lancet·A J KARLISH, A L TARNOKY

❮ Previous
Next ❯

Citations

Jan 22, 2002·Pediatric Pulmonology·Gerald T O'ConnorUNKNOWN Northern New England Cystic Fibrosis Consortium
Apr 1, 1993·Social Science & Medicine·W BorG Williams
Mar 1, 1995·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·S M SawyerG Bowes
Mar 20, 1998·The Journal of Pediatrics·M S Schechter, P A Margolis
Apr 30, 1992·The New England Journal of Medicine·E KeremH Levison
Sep 5, 2003·The New England Journal of Medicine·Wylie Burke
Dec 1, 1996·The Laryngoscope·J M Rowe-Jones, I S Mackay
Sep 24, 2005·Archives of Disease in Childhood·B D CallaghanS B Carr
Jan 1, 1990·Archives of Disease in Childhood·T J David
Oct 1, 1990·Archives of Disease in Childhood·R I Russell, P J Helms
Jun 1, 1991·Archives of Disease in Childhood·R Scott-JuppM S Tanner
Jan 1, 1993·Archives of Disease in Childhood·I M BowlerJ M Littlewood
May 1, 1997·Archives of Disease in Childhood·R Reading
Apr 8, 1989·BMJ : British Medical Journal·P A Lewis
Feb 27, 1993·BMJ : British Medical Journal·S WaltersM E Hodson
May 24, 2001·American Journal of Respiratory and Critical Care Medicine·M S SchechterS C Fitzsimmons
Feb 11, 2009·Paediatric Respiratory Reviews·Linda L Wolfenden, Michael S Schechter
May 1, 2007·Pediatric Pulmonology·J M CourtneyJ S Elborn
Nov 5, 1997·Clinics in Chest Medicine·S Manaker, G Tino
Mar 9, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Jonathan McCormickAnil Mehta
Jul 1, 1993·Respiratory Medicine·D Peckham, A Knox
Jun 9, 2016·Expert Review of Respiratory Medicine·Gabriela R Oates, Michael S Schechter
Aug 1, 1991·Journal of Paediatrics and Child Health·D L JollyG Vimpani
Jul 23, 2009·Journal of the Royal Society of Medicine·Atul GuptaMark Rosenthal
Apr 16, 2011·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery·Lara C KovellEmily F Boss
Jun 15, 2012·Journal of the Royal Society of Medicine·David Honeybourne
Apr 14, 2000·Clinical Otolaryngology and Allied Sciences·P J HadfieldI S Mackay
Dec 1, 1993·Archives of Disease in Childhood·M A Tatman, C Woodroffe
Mar 25, 1989·BMJ : British Medical Journal
Aug 1, 1996·Journal of Paediatrics and Child Health·A T Westwood
Feb 24, 2001·Annals of Tropical Paediatrics·P A CamargosF J Reis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
E KeremH Levison
Archives of Disease in Childhood
J S FallonJ M Littlewood
BMJ : British Medical Journal
David C Taylor-Robinson, Michael S Schechter
© 2022 Meta ULC. All rights reserved